全文获取类型
收费全文 | 687634篇 |
免费 | 11483篇 |
国内免费 | 1910篇 |
专业分类
电工技术 | 12182篇 |
综合类 | 656篇 |
化学工业 | 101964篇 |
金属工艺 | 25929篇 |
机械仪表 | 19771篇 |
建筑科学 | 16894篇 |
矿业工程 | 3355篇 |
能源动力 | 18653篇 |
轻工业 | 61224篇 |
水利工程 | 6992篇 |
石油天然气 | 11985篇 |
武器工业 | 47篇 |
无线电 | 77285篇 |
一般工业技术 | 133547篇 |
冶金工业 | 136873篇 |
原子能技术 | 13888篇 |
自动化技术 | 59782篇 |
出版年
2021年 | 6537篇 |
2020年 | 4876篇 |
2019年 | 6053篇 |
2018年 | 10545篇 |
2017年 | 10400篇 |
2016年 | 10929篇 |
2015年 | 7527篇 |
2014年 | 12234篇 |
2013年 | 32398篇 |
2012年 | 19513篇 |
2011年 | 26150篇 |
2010年 | 20668篇 |
2009年 | 22975篇 |
2008年 | 23641篇 |
2007年 | 23158篇 |
2006年 | 20079篇 |
2005年 | 18342篇 |
2004年 | 17604篇 |
2003年 | 17316篇 |
2002年 | 16210篇 |
2001年 | 16232篇 |
2000年 | 15253篇 |
1999年 | 16188篇 |
1998年 | 42420篇 |
1997年 | 29664篇 |
1996年 | 22654篇 |
1995年 | 16794篇 |
1994年 | 14762篇 |
1993年 | 14300篇 |
1992年 | 10329篇 |
1991年 | 9757篇 |
1990年 | 9517篇 |
1989年 | 9275篇 |
1988年 | 8557篇 |
1987年 | 7559篇 |
1986年 | 7371篇 |
1985年 | 8326篇 |
1984年 | 7773篇 |
1983年 | 6942篇 |
1982年 | 6429篇 |
1981年 | 6649篇 |
1980年 | 6233篇 |
1979年 | 6196篇 |
1978年 | 6014篇 |
1977年 | 7160篇 |
1976年 | 9664篇 |
1975年 | 5169篇 |
1974年 | 4853篇 |
1973年 | 4956篇 |
1972年 | 4061篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
Kazuo Tsubota Stephen C. Pflugfelder Zuguo Liu Christophe Baudouin Hyo Myung Kim Elisabeth M. Messmer Friedrich Kruse Lingyi Liang Jimena Tatiana Carreno-Galeano Maurizio Rolando Norihiko Yokoi Shigeru Kinoshita Reza Dana 《International journal of molecular sciences》2020,21(23)
Over the past decades, the number of patients with dry eye disease (DED) has increased dramatically. The incidence of DED is higher in Asia than in Europe and North America, suggesting the involvement of cultural or racial factors in DED etiology. Although many definitions of DED have been used, discrepancies exist between the various definitions of dry eye disease (DED) used across the globe. This article presents a clinical consensus on the definition of DED, as formulated in four meetings with global DED experts. The proposed new definition is as follows: “Dry eye is a multifactorial disease characterized by a persistently unstable and/or deficient tear film (TF) causing discomfort and/or visual impairment, accompanied by variable degrees of ocular surface epitheliopathy, inflammation and neurosensory abnormalities.” The key criteria for the diagnosis of DED are unstable TF, inflammation, ocular discomfort and visual impairment. This definition also recommends the assessment of ocular surface epitheliopathy and neurosensory abnormalities in each patient with suspected DED. It is easily applicable in clinical practice and should help practitioners diagnose DED consistently. This consensus definition of DED should also help to guide research and clinical trials that, to date, have been hampered by the lack of an established surrogate endpoint. 相似文献
132.
133.
L. S. Belevskii M. A. Levantsevich R. R. Dema L. V. Deryabina T. V. Usataya O. R. Latypov 《Russian Engineering Research》2020,40(5):390-395
The machining of metal surfaces and the application of functional coatings by means of a flexible tool (a rotating wire brush) is considered. Frictional cladding may be applied on metal-cutting machines by means of simple attachments or manual angle grinders. 相似文献
134.
135.
136.
137.
138.
139.
140.
Nicholas Caffes David B. Kurland Volodymyr Gerzanich J. Marc Simard 《International journal of molecular sciences》2015,16(3):4973-4984
Ischemic and hemorrhagic strokes are associated with severe functional disability and high mortality. Except for recombinant tissue plasminogen activator, therapies targeting the underlying pathophysiology of central nervous system (CNS) ischemia and hemorrhage are strikingly lacking. Sur1-regulated channels play essential roles in necrotic cell death and cerebral edema following ischemic insults, and in neuroinflammation after hemorrhagic injuries. Inhibiting endothelial, neuronal, astrocytic and oligodendroglial sulfonylurea receptor 1–transient receptor potential melastatin 4 (Sur1–Trpm4) channels and, in some cases, microglial KATP (Sur1–Kir6.2) channels, with glibenclamide is protective in a variety of contexts. Robust preclinical studies have shown that glibenclamide and other sulfonylurea agents reduce infarct volumes, edema and hemorrhagic conversion, and improve outcomes in rodent models of ischemic stroke. Retrospective studies suggest that diabetic patients on sulfonylurea drugs at stroke presentation fare better if they continue on drug. Additional laboratory investigations have implicated Sur1 in the pathophysiology of hemorrhagic CNS insults. In clinically relevant models of subarachnoid hemorrhage, glibenclamide reduces adverse neuroinflammatory and behavioral outcomes. Here, we provide an overview of the preclinical studies of glibenclamide therapy for CNS ischemia and hemorrhage, discuss the available data from clinical investigations, and conclude with promising preclinical results that suggest glibenclamide may be an effective therapeutic option for ischemic and hemorrhagic stroke. 相似文献